Price
93.66
-2.69%52W Range
Market Cap
₹220.52 Cr
Traded: ₹0.38 Cr (0.17%) 0.0x
Free Float: ₹72.42 Cr (0.52% of FF traded)
Volume · 60D trend
39.39 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -46.0% | -6.0% | -4.0% | -- | -- | Accelerating |
| Return | +3.0% | -5.0% | -12.0% | -4.0% | -- | Stable |
| Sales | -12.0% | +3.0% | -9.0% | -- | -1.0% | Stable |
| Profit | -9.0% | +16.0% | +37.0% | -- | +248.0% | Accelerating |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 226 | 188 | 181 | 178 | 186 | 194 | 198 | 202 | 194 | 200 | 175 | 190 | 182 | 234 |
| Expenses | 189 | 171 | 168 | 175 | 175 | 186 | 187 | 194 | 175 | 208 | 158 | 173 | 169 | 219 |
| Operating Profit | 37 | 17 | 13 | 3 | 11 | 8 | 11 | 8 | 19 | -8 | 17 | 17 | 13 | 14 |
| OPM % | 16.0% | 9.0% | 7.0% | 1.9% | 6.0% | 4.0% | 5.0% | 3.8% | 10.0% | -4.1% | 10.0% | 9.0% | 7.0% | 6.2% |
| Other Income | 0 | 12 | 3 | 4 | 6 | 21 | -6 | -6 | 4 | 9 | 4 | 1 | 3 | 231 |
| Interest | 18 | 18 | 17 | 19 | 19 | 19 | 19 | 24 | 21 | 23 | 21 | 20 | 19 | 11 |
| Depreciation | 4 | 5 | 5 | 12 | 12 | 5 | 12 | 11 | 12 | 13 | 11 | 10 | 10 | 9 |
| Profit Before Tax | 15 | 7 | -6 | -24 | -13 | 6 | -27 | -33 | -10 | -35 | -10 | -13 | -13 | 225 |
| Tax % | -1.0% | -13.0% | 3.0% | -1.0% | -25.0% | -119.0% | -40.0% | -10.0% | 55.0% | -44.0% | 34.0% | -5.0% | -1.0% | 65.2% |
| Net Profit | 15 | 8 | -6 | -23 | -10 | 12 | -16 | -30 | -15 | -20 | -14 | -12 | -13 | 78 |
| Exceptional Items | -2 | -2 | -2 | 0 | 0 | 14 | -10 | -10 | 0 | 4 | 0 | -10 | -1 | 227 |
| EPS (Rs) | 5.4 | 5.7 | 0.4 | -5.3 | -1.6 | 7.5 | -3.0 | -6.8 | -2.7 | -4.6 | -2.9 | -3.2 | -3.4 | 19.6 |
| Sales Growth (YoY) | 21.5% | -3.1% | -8.6% | -11.9% | -4.1% | -3.0% | 13.1% | 6.3% | 6.6% | -14.4% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 20.2% | 3.9% | 1.7% | -4.3% | -4.1% | -2.0% | -2.0% | 4.1% | -3.0% | 14.3% | -7.9% | 4.4% | -22.1% | -- |
| OP Growth (YoY) | 236.4% | 112.5% | 18.2% | -62.5% | -42.1% | 200.0% | -35.3% | -52.9% | 46.2% | -155.4% | -- | -- | -- | -- |
| OP Growth (QoQ) | 117.6% | 30.8% | 333.3% | -72.7% | 37.5% | -27.3% | 37.5% | -57.9% | 337.5% | -147.1% | 0.0% | 30.8% | -9.9% | -- |
| Profit Growth (YoY) | 473.0% | 301.0% | 197.0% | -15.0% | 41.0% | 130.0% | 59.0% | -552.0% | 14.0% | -1729.0% | 43.0% | 86.0% | -21.0% | 78.0% |
| EPS Growth (YoY) | 434.8% | -24.0% | 113.5% | 22.9% | 40.6% | 261.3% | -4.5% | -111.5% | 19.4% | -123.6% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -5.1% | 1285.4% | 107.8% | -226.1% | -121.5% | 345.7% | 55.4% | -151.3% | 41.5% | -59.1% | 9.6% | 4.2% | -117.1% | -- |
| OP Margin | 16.4% | 9.0% | 7.2% | 1.7% | 5.9% | 4.1% | 5.6% | 4.0% | 9.8% | -4.0% | 9.7% | 8.9% | 7.1% | 6.2% |
| Net Margin | 6.6% | 4.3% | -3.3% | -12.9% | -5.4% | 6.2% | -8.1% | -14.8% | -7.7% | -10.0% | -8.0% | -6.3% | -7.1% | 33.5% |
| Material Cost % | 62.0% | 62.0% | 66.0% | 72.0% | 67.0% | 67.0% | 67.0% | 71.0% | 65.0% | 70.0% | 63.0% | 68.0% | 67.0% | 80.0% |
| Employee Cost % | 9.0% | 10.0% | 12.0% | 11.0% | 11.0% | 11.0% | 11.0% | 10.0% | 9.0% | 9.0% | 10.0% | 9.0% | 10.0% | 7.0% |
| P/S | 0.29 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 15.03 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 1.12 | 0.77 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Guttikonda Rajasekhar & Others
Bilcare Limited has informed the Exchange about the Newspaper Publication of Quarterly Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June 2026.
Bilcare Limited has informed the Exchange about the appointment of Company Secretary, Compliance Officer and Key Managerial Personnel
Bilcare Limited has informed the Exchange about the Voluntary winding up of wholly owned subsidiary.
Bilcare Limited has informed the Exchange aabout the Resignation of Company Secretary, Compliance Officer and Key Managerial Personnel
Bilcare Limited has informed the Exchange about the appointment of Mr. Mohan Bhandari as an Executive Director of the Company and reappointment of Ms. Kavita Bhansali as Executive Director ....
Bilcare Limited has informed the Exchange about Standalone & Consolidated Unaudited Financial Results for the quarter ended on 30 June 2026 along with Limited Review Report issued by Statutory ....
Bilcare Limitedhas informed the Exchange about the outcome of Board Meeting.
Bilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Unaudited Financial Results (Standalone ....
Bilcare Limited has submitted the Scrutinizer''s Report and Voting Results regarding Postal Ballot conducted.
Bilcare Limited has submitted the Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30 June 2026.
Bilcare Limited has submitted intimation towards closure of trading window.
Bilcare Limited has informed the Exchange about Newspaper Publication regarding Postal Ballot Notice and Remote e-voting.
Bilcare Limited has informed the Exchange about Notice of Postal Ballot.
Bilcare Limited has submitted to the Exchange about the disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regualtions, 2015 - Order of Hon''ble ....
Newspaper publication of Audited Financial Results (Standalone and Consolidated) for the Quarter and Year Ended 31st March 2026.
Bilcare Limited has submitted the Annual Secretarial Compliance Report for the year ended on 31 March 2026.
Bilcare Limited has informed the Exchange about the following: a) Redemption of Preference Shares and b) Conversion of Warrants and Allotment of Equity Shares
Bilcare Limited has informed the Exchnage that the Board of Directors in their Meeting held on 29 May 2026 have approved Audited Financial Results (Standalone and Consolidated) for the ....
Bilcare Limited has informed the Exchange about the outcome of Board Meeting held on 29 May 2026
Bilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve the Audited Financial Results (Standalone ....
Bilcare Limited has informed the Exchange that the Non - applicability of Large Corporate Category.
Bilcare Limited has informed the Exchange about the Cessation due to Completion of Second Term as an Independent Director Mrs. Madhuri Vaidya effective from end of business hours on 26 April 2026.
Bilcare Limited has informed the Exchange about the 1. Cessation due to Completion of Second term as an Independent Director Mrs. Madhuri Vaidya 2. Appointment of Advocate Ashwini Ashok ....
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 31st March, 2026.
Bilcare Limited has informed the Exchange about the Outcome of Board meeting held on March 30, 2026.
Bilcare Limited has informed the Exchange about the update on Voluntary Liquidation of Wholly Owned Subsidiary Company.
Bilcare Limited has informed the Exchange about the following; a) Redemption of Preference Shares b) Conversion of Warrants and Allotment of Equity Shares c) Update on Voluntary liquidation ....
Intimation of Closure of Trading Window for Audited Financial Results for the Quarter and Year ended March 31, 2026
Newspaper publication of Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Nine Months ended 31st December, 2025.
Bilcare Limited has informed the Exchange about that Exercise of Right of Conversion of Convertible Warrants
Bilcare Limited has informed the Exchange about the Redemption of Preference Shares held by the Company in Caprihans India Limited.
Bilcare Limited has informed the Exchange about the approval of Unaudited Financial Results (Standalone and Consolidated) for the period ended 31.12.2025 along with Limited Review Report.
Bilcare Limited has informed the exchange about the outcome of Board Meeting and approval of Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2025.
Bilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve the Un-Audited Financial Results For ....
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 31st December, 2025.
Bilcare Limited has informed the Exchange about change in Email address of the Registrar and Transfer Agent of the Company.
Intimation for Closure of Trading Window for Unaudited Financial Results for the Quarter and Nine Months ended December 31, 2025.
Newspaper publication of Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year ended 30th September, 2025.
Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended 30.09.2025 along with Limited Review Report.
Approval of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September 2025
Bilcare Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Un-Audited Financial Results For ....
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Guttikonda Rajasekhar
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 30th September, 2025.
Intimation for Closure of Trading Window for Unaudited Financial Results for the Quarter and Half Year ended September 30, 2025.
Voting Results of 38th Annual General Meeting and Scrutinizers Report
Proceedings of 38th Annual General Meeting held on September 24, 2025- Revised
Proceedings of 38th Annual General Meeting held on September 24, 2025
Intimation regarding change in Website of the Company
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Guttikonda Rajasekhar